Literature DB >> 11319846

Locoregionally recurrent breast cancer: incidence, risk factors and survival.

M Clemons1, S Danson, T Hamilton, P Goss.   

Abstract

Locoregional recurrence (LRR) after therapy for early breast cancer is common. Patients with LRR can suffer both local consequences and symptoms of metastatic disease, as LRR is an independent predictor of subsequent distant metastases. Much of the available data on LRR is derived from small, single institution, retrospective studies, so marked differences in the incidence rates for LRR, it's risk factors and subsequent systemic recurrence are reported. The purpose of this review was to try and collate this data in a format that would be useful for both clinicians and their patients. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11319846     DOI: 10.1053/ctrv.2000.0204

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  24 in total

1.  CXCR-4 Targeted, Short Wave Infrared (SWIR) Emitting Nanoprobes for Enhanced Deep Tissue Imaging and Micrometastatic Cancer Lesion Detection.

Authors:  Margot Zevon; Vidya Ganapathy; Harini Kantamneni; Marco Mingozzi; Paul Kim; Derek Adler; Yang Sheng; Mei Chee Tan; Mark Pierce; Richard E Riman; Charles M Roth; Prabhas V Moghe
Journal:  Small       Date:  2015-10-30       Impact factor: 13.281

Review 2.  Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review.

Authors:  Sergio Maluta; Merel Willemijn Kolff
Journal:  Breast Care (Basel)       Date:  2015-10-16       Impact factor: 2.860

3.  Early-stage breast cancer conservative treatment: high-dose-rate brachytherapy boost in a single fraction of 700 cGy to the tumour bed.

Authors:  Aurora Rodríguez Pérez; Pilar María Samper Ots; María Concepción López Carrizosa; José Fermín Pérez-Regadera Gómez; José Zapatero Ortuño; Juan de Dios Sáez Garrido; Manuel Joaquín Martín de Miguel
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

4.  Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.

Authors:  James Laird; Benjamin Lok; Chun Siu; Oren Cahlon; Atif J Khan; Beryl McCormick; Simon N Powell; Hiram Cody; Hannah Yong Wen; Alice Ho; Lior Z Braunstein
Journal:  Ann Surg Oncol       Date:  2017-11-01       Impact factor: 5.344

5.  Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?

Authors:  Francesca Magnoni; M Colleoni; D Mattar; G Corso; V Bagnardi; S Frassoni; G Santomauro; B A Jereczek-Fossa; P Veronesi; V Galimberti; V Sacchini; M Intra
Journal:  Ann Surg Oncol       Date:  2020-05-21       Impact factor: 5.344

6.  Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial.

Authors:  Stefan Aebi; Shari Gelber; Stewart J Anderson; István Láng; André Robidoux; Miguel Martín; Johan W R Nortier; Alexander H G Paterson; Mothaffar F Rimawi; José Manuel Baena Cañada; Beat Thürlimann; Elizabeth Murray; Eleftherios P Mamounas; Charles E Geyer; Karen N Price; Alan S Coates; Richard D Gelber; Priya Rastogi; Norman Wolmark; Irene L Wapnir
Journal:  Lancet Oncol       Date:  2014-01-16       Impact factor: 41.316

7.  Is routine histological examination of mastectomy scars justified? An analysis of 619 scars.

Authors:  Arash Momeni; Pelu Tran; Jonathan Dunlap; Gordon K Lee
Journal:  J Plast Reconstr Aesthet Surg       Date:  2012-10-06       Impact factor: 2.740

8.  Breast cancer recurrence: follow up after treatment for primary breast cancer.

Authors:  N Hiramanek
Journal:  Postgrad Med J       Date:  2004-03       Impact factor: 2.401

9.  Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01).

Authors:  Heather B Neuman; Jessica R Schumacher; Amanda B Francescatti; Taiwo Adesoye; Stephen B Edge; David J Vanness; Menggang Yu; Daniel McKellar; David P Winchester; Caprice C Greenberg
Journal:  J Clin Oncol       Date:  2018-01-31       Impact factor: 44.544

10.  Long-term Follow-up of Autologous Fat Transfer vs Conventional Breast Reconstruction and Association With Cancer Relapse in Patients With Breast Cancer.

Authors:  Todor Krastev; Arjen van Turnhout; Eline Vriens; Luc Smits; René van der Hulst
Journal:  JAMA Surg       Date:  2019-01-01       Impact factor: 14.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.